Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, et al.
Cell Metabolism (2018) Vol. 29, Iss. 1, pp. 18-26
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

Hepatocellular carcinoma
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4516
Inflammation in obesity, diabetes, and related disorders
Theresa V. Rohm, Daniel T. Meier, Jerrold M. Olefsky, et al.
Immunity (2022) Vol. 55, Iss. 1, pp. 31-55
Open Access | Times Cited: 1140
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 367
Targeting innate immune mediators in type 1 and type 2 diabetes
Marc Y. Donath, Charles A. Dinarello, Thomas Mandrup‐Poulsen
Nature reviews. Immunology (2019) Vol. 19, Iss. 12, pp. 734-746
Closed Access | Times Cited: 334
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 487-503
Closed Access | Times Cited: 195
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 189
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
Jiajie Hou, Haiyan Zhang, Beicheng Sun, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 1, pp. 167-182
Open Access | Times Cited: 154
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
Fuming Li, Peiwei Huangyang, Michelle Burrows, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 6, pp. 728-739
Open Access | Times Cited: 154
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1043-1054
Open Access | Times Cited: 146
Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH
Tim Hendrikx, Florentina Porsch, Máté G. Kiss, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1373-1385
Closed Access | Times Cited: 125
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Junliang Kuang, Jieyi Wang, Yitao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1752-1766.e8
Open Access | Times Cited: 125
A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD
Yu Ri Im, Harriet Hunter, Dana de Gracia Hahn, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1884-1901
Open Access | Times Cited: 121
Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma
Yeming Yang, Jingshu Cai, Xue Yang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2342-2353
Open Access | Times Cited: 118
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development
Xiaochen Wang, Qifeng He, Chuanli Zhou, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 58-77.e11
Open Access | Times Cited: 118
UCP1 governs liver extracellular succinate and inflammatory pathogenesis
Evanna L. Mills, Cathal Harmon, Mark P. Jedrychowski, et al.
Nature Metabolism (2021) Vol. 3, Iss. 5, pp. 604-617
Open Access | Times Cited: 117
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 111
Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 106
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Mark A. Febbraio, Michael Karin
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2316-2328
Open Access | Times Cited: 106
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Weiguo Fan, Kolade Adebowale, Lóránd Váncza, et al.
Nature (2024) Vol. 626, Iss. 7999, pp. 635-642
Open Access | Times Cited: 89
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 45
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure
Stefan Zwirner, Anan Abu Rmilah, Sabrina Klotz, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1666-1684.e26
Open Access | Times Cited: 24
Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring
Jonathan Sun, Enric Esplugues, Alicia Bort, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 741-763
Closed Access | Times Cited: 20
A Guide to Pathophysiology, Signaling Pathways, and Preclinical Models of Liver Fibrosis
Marjia Sultana, Md Asrarul Islam, Rhema Khairnar, et al.
Molecular and Cellular Endocrinology (2025), pp. 112448-112448
Closed Access | Times Cited: 3
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease
Marc Y. Donath, Daniel T. Meier, Marianne Böni‐Schnetzler
Endocrine Reviews (2019) Vol. 40, Iss. 4, pp. 1080-1091
Open Access | Times Cited: 97
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress
Sabira Mohammed, Evan H. Nicklas, Nidheesh Thadathil, et al.
Free Radical Biology and Medicine (2021) Vol. 164, pp. 315-328
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top